monobromobimane has been researched along with alpha-chymotrypsin in 2 studies
| Studies (monobromobimane) | Trials (monobromobimane) | Recent Studies (post-2010) (monobromobimane) | Studies (alpha-chymotrypsin) | Trials (alpha-chymotrypsin) | Recent Studies (post-2010) (alpha-chymotrypsin) |
|---|---|---|---|---|---|
| 199 | 1 | 42 | 14,743 | 142 | 1,015 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ue, K | 1 |
| Hudig, D; Redelman, D | 1 |
2 other study(ies) available for monobromobimane and alpha-chymotrypsin
| Article | Year |
|---|---|
Intramolecular cross-linking of myosin subfragment 1 with bimane.
Topics: Animals; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Chymotrypsin; Cross-Linking Reagents; Cyanogen Bromide; Dithionitrobenzoic Acid; Fluorescent Dyes; Kinetics; Mercaptoethanol; Muscles; Myosin Subfragments; Myosins; Peptide Fragments; Rabbits | 1987 |
The mechanism of cell-mediated cytotoxicity. III. Protease-specific inhibitors preferentially block later events in cytotoxic T lymphocyte-mediated lysis than do inhibitors of methylation or thiol-reactive agents.
Topics: Adenosine; alpha 1-Antichymotrypsin; Animals; Bridged Bicyclo Compounds; Calcium; Chymotrypsin; Coformycin; Cytotoxicity, Immunologic; Deoxyadenosines; Methylation; Mice; Mice, Inbred Strains; Pentostatin; Peptide Hydrolases; Sulfhydryl Compounds; T-Lymphocytes, Cytotoxic; Time Factors; Tyrosine | 1983 |